Trending...
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- Valgar LLC Launches The Briefing Room: Education Leaders
AI.Reverie honored for achievements advancing computer vision with synthetic data
NEW YORK - illiNews -- CB Insights today named AI.Reverie, the leading synthetic data platform, to its annual AI 100 ranking of the most promising private artificial intelligence companies in the world for the second time.
"This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are honored to be named to CB Insights' AI 100 List again," said AI.Reverie co-founder and CEO Daeil Kim. "Synthetic data is now a must-have, and more and more enterprises, government agencies and NGOs are tapping the AI.Reverie platform to accelerate AI development while protecting data privacy. The world-changing outcomes our customers achieve with our platform are the ultimate prize."
More on illi News
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.
During 2020, AI.Reverie grew 3x as the demand for synthetic data to train vision algorithms spiked. Other milestones in the last year included:
About CB Insights
More on illi News
CB Insights builds software that enables the world's best companies to discover, understand and make technology decisions with confidence. By marrying data, expert insights and work management tools, clients manage their end-to-end technology making process on CB Insights. To learn more, please visit www.cbinsights.com.
About AI.Reverie
The AI.Reverie synthetic data platform creates a virtually endless supply of annotated images and videos that accelerate computer vision and machine learning across domains. Its unique toolset preserves data privacy and provides the control to prevent bias in AI. Learn more at www.aireverie.com.
"This year's cohort spans 18 industries, and is working on everything from climate risk to accelerating drug R&D," said CB Insights CEO Anand Sanwal. "Last year's AI 100 companies had a remarkable run after being named to the list, with more than 50% going on to raise additional financing (totaling $5.2B), including 16 $100 million+ mega-rounds. Many also went on to exit via M&A, SPAC or IPO. As industry after industry adopts AI, we expect this year's class will see similar levels of interest from investors, acquirers and customers."
"We are honored to be named to CB Insights' AI 100 List again," said AI.Reverie co-founder and CEO Daeil Kim. "Synthetic data is now a must-have, and more and more enterprises, government agencies and NGOs are tapping the AI.Reverie platform to accelerate AI development while protecting data privacy. The world-changing outcomes our customers achieve with our platform are the ultimate prize."
More on illi News
- 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne
- Scott G. Hoy of Hoy Law Earns 11th Consecutive Super Lawyers Selection
- L2 Aviation Selected for U.S. Air Force KC-46 CASPER Multiple Award Contract
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.
During 2020, AI.Reverie grew 3x as the demand for synthetic data to train vision algorithms spiked. Other milestones in the last year included:
- An expansion of offerings into the Retail and Agriculture markets
- Inclusion in the United States Air Force's $3.3B, five-year Advance Battle Management System (ABMS) program
- A $1.5M AFWERX Phase 2 SBIR contract
- A $5.6M round of equity financing led by Vulcan
- The release of the largest open dataset of real and synthetic overhead imagery (Rareplanes, with the In-Q-Tel lab CosmiQ Works)
- Gartner recognition as a "Cool Vendor" in AI Core Technologies
- Forbes recognition as a "Top 25 Machine Learning Start-up," among other honors
About CB Insights
More on illi News
- KeysCaribbean Resorts Offer Savings On Summer Vacations Now Through Aug. 31
- Mayor Brandon Johnson and the Chicago Department of Business Affairs and Consumer Protection Launch Driver Resource Center
- Crossroads4Hope Announces The Lipschutz Women's Fund
- ZenSpinner Introduces an Innovative Automated Singing Bowl Experience for Meditation and Wellness
- Axis International Showcases the RLT Body Suit—A Patented Concept for Wearable Full-Body Red Light Therapy
CB Insights builds software that enables the world's best companies to discover, understand and make technology decisions with confidence. By marrying data, expert insights and work management tools, clients manage their end-to-end technology making process on CB Insights. To learn more, please visit www.cbinsights.com.
About AI.Reverie
The AI.Reverie synthetic data platform creates a virtually endless supply of annotated images and videos that accelerate computer vision and machine learning across domains. Its unique toolset preserves data privacy and provides the control to prevent bias in AI. Learn more at www.aireverie.com.
Source: AI.Reverie
0 Comments
Latest on illi News
- Chris The Wiz Releases Can't Tell EP
- Elevate Your Sneakers With Crep Protect Trek Laces
- Meet Privateer: Tucson's High-Tech Security Force Built With Paramilitary Precision
- Axis International Presents Innovative Spoon Rest with Hinged Lid for Licensing Opportunities
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- Sunny The Sandman Brings Coastal Charm and Seasonal Decorating Together in One Illuminated Home Décor Concept
- DARPA Selects NRx Pharmaceuticals Defense Subsidiary for Contract Negotiations on FDA-Authorized SPARC-TMS Clinical Trial Advancing Mental Health Care
- Body-Solid Launches the GSFR100 All-In-One Functional Trainer/Smith Machine
- From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
- Valgar LLC Launches The Briefing Room: Education Leaders
- X2Griffon Flight Trajectory Predictions Advance; MSDS Activates BLE Ground Recovery Technology
- New Novel WINCE Takes Unflinching Aim at American Gun Culture and Masculinity
- New Research Puts the Cost of Enterprise Decision Delay at $630 Billion a Year Across the Global 2000
- Mayor Brandon Johnson, Chicago Youth Works on Track to Hire 29,000 Young People, Hitting Summer Youth Employment Goal Four Years in a Row
- Axis International Introduces the Smart Heated Floor Runner, Bringing Smart Comfort to Every Step
- Axis international introduces Comfort Creatures
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- Naperville: Municipal Election Petitions for Candidacy Available Tuesday, July 28
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
